Accelerated Aging Testing

One of the first and most important steps in any aging program is defining what success, and failure, really mean for the product in its intended use.

For some products, failure may be obvious. A crack forms, a seal leaks, or a component breaks. But in many medical applications, performance changes are more subtle. A tubing formulation may become stiffer over time. A closure liner may lose reseal performance. A transparent component may discolor. A material may retain its appearance while losing a property that is important to flexibility, pressure resistance, or long-term sealing. In other words, aging does not always announce itself dramatically.

That is why service-life estimation works best when it starts with a clear chain of logic:

• What does the product need to do in the field? Which material properties support that function?
• Which environmental conditions is it likely to see during storage or use?
• And which degradation mechanisms are most likely to matter over time?

Those questions help define the framework for a useful accelerated aging study. They also remind us that aging is not one single phenomenon. Depending on the material and application, the critical mechanism might involve oxidation, hydrolysis, additive depletion, stress cracking, radiation effects, creep, or diffusion-related changes. Different products can look similar on the surface and still age in very different ways because their chemistry, construction, and performance requirements are not the same.

This is one reason why material selection and aging strategy are so closely connected. The more clearly we understand how a product is expected to perform, and how its materials are likely to respond over time, the more confidently we can design a study that reflects real-world behavior.

Temperature is by far the most common stressor used in accelerated aging, and for good reason. Many chemical degradation processes speed up as temperature increases. When molecules have more thermal energy, reactions such as oxidation, chain scission, or hydrolysis often proceed more quickly, which makes heat a practical tool for compressing time.

This is the basis for ASTM F1980, a well-known standard in the medical device industry that provides a framework for accelerated aging, particularly for sterile barrier systems and packaged devices. One of the concepts commonly used within that framework is Q10, which estimates how much the rate of degradation increases with each 10 °C rise in temperature.

A common assumption is Q10 = 2. In simple terms, that means the degradation rate is assumed to double for every 10 °C increase. So, if a product is aged at 60 °C instead of 20 °C, the 40-degree difference corresponds to four 10-degree steps, which gives an acceleration factor of 16. Under that assumption, one month at 60 °C would represent about sixteen months at 20 °C.

This kind of framework is useful because it gives teams a practical way to move forward. It helps create structure around study design and can support shelf-life planning when time matters. But like any model, it works best when the underlying assumptions fit the product being tested.

Why the material still matters

One of the easiest ways to oversimplify accelerated aging is to assume that a single acceleration factor applies equally well across very different materials.

In practice, that is not always the case.

Different polymers and elastomers do not all respond to temperature in the same way. Even when two products are aged at the same temperature and appear to reach the same endpoint in the same amount of time, their projected behavior under normal conditions may still be very different.

Imagine two products tested at 60 °C. Both fail after two months. At first glance, the result may look equivalent. But if Product A has an effective Q10 of 2 and Product B has an effective Q10 of 4, the interpretation changes dramatically. Relative to storage at 20 °C, Product A would have an acceleration factor of 16, while Product B would have an acceleration factor of 256. The oven data may look similar, but the projected life at ambient conditions is not.

That is why comparative aging studies deserve careful thought, especially when products are made from dissimilar materials such as vinyl and silicone. The chemistry is different. The additive package may be different. Oxygen permeability may be different. Thermal transitions may be different. All of those factors can influence how a material ages and how confidently elevated-temperature data can be extrapolated back to normal conditions.

This does not mean accelerated comparisons are not useful. It simply means they are strongest when they are grounded in an understanding of what each material is actually doing under the test conditions.

Q10 is widely used because it is practical, familiar, and often appropriately conservative. But it is still a shortcut.

For teams that need a more rigorous understanding of temperature sensitivity, Arrhenius-based methods can provide a stronger foundation. ASTM D7160 outlines an approach for determining an accelerated aging factor based on the kinetics of the actual degradation process. At the center of that approach is the recognition that degradation reactions do not all respond to temperature with the same sensitivity.

That matters because a default Q10 assumption is not a universal property of aging. It is an approximation. Some materials may track that assumption reasonably well across a relevant temperature range. Others may not. And the farther a study moves from the actual chemistry of the product, the harder it becomes to know how representative that simplification really is.

For many teams, the takeaway is not that every aging study needs to become a full Arrhenius exercise. It is that acceleration factors should be chosen thoughtfully, especially when products differ in composition, when long life claims are being made, or when the cost of getting the prediction wrong is high.

A little more upfront material understanding can go a long way toward making accelerated data more meaningful.

The most important question: are we accelerating the right mechanism?

This is really the heart of the matter.

A useful accelerated aging study should speed up the same degradation pathway that governs real-time aging. If the mechanism changes under the elevated condition, the study may still generate data, but that data becomes harder to use as a reliable predictor of real-world behavior.

This is why the choice of test condition matters so much. Heat is helpful, but only within a range where the product still behaves in a relevant way. If the aging temperature pushes a material through an important thermal transition, changes crystallinity, increases additive mobility, releases internal stresses, or introduces a different physical state than the one seen in actual storage, the relationship to real-time aging may become less clear.

That does not mean elevated testing should be avoided. It means the test should be chosen with care.

In many cases, a slightly less aggressive protocol can be more informative than a very aggressive one, because it preserves the connection between accelerated aging and real-world aging more effectively. The goal is not to get the fastest answer available. It is to get an answer that remains useful when translated back to actual conditions.

That is also why an understanding of thermal transitions, formulation behavior, and product construction can be so important. A material does not need to melt to begin behaving differently. Sometimes a modest shift in morphology or mobility is enough to make the test less representative than it appears at first glance.

Real products often face more than one stressor

Temperature is often a very helpful starting point, but many products age under the influence of more than heat alone.

Humidity may matter for moisture-sensitive polymers or adhesive systems. Radiation may matter for sterilized components or products exposed to light. Chemicals may affect swelling, extraction, stress cracking, or long-term compatibility. Mechanical loading can influence creep, fatigue, or crack growth. In some products, oxygen availability or diffusion through the material can become just as important as the reaction rate itself.

This is where accelerated aging can become more complex, but also more valuable. The right study design should reflect the actual environment the product is expected to experience. If the real challenge is a combination of temperature and humidity, a dry thermal study may only tell part of the story. If a component will spend its life in contact with an aggressive fluid, chemical compatibility may be central to long-term performance. If the system is thick-walled or low-permeability, diffusion may control the rate of change more than simple reaction kinetics.

These cases are a good reminder that aging studies are most useful when they are built around the product, rather than forcing the product into a one-size-fits-all testing model.

Some systems are reaction-limited. Others are diffusion-limited. Some are governed by one dominant stressor, while others are shaped by interactions between several. Recognizing that complexity is not a weakness in the test plan. It is often the beginning of a better one.

It is also helpful to distinguish between shelf life and service life, because they are related but not interchangeable.

Shelf life generally refers to how long a product can remain in storage and still meet requirements at the time of use. For medical devices, that may involve packaging integrity, sterility maintenance, seal strength, barrier performance, and retention of critical properties after storage.

Service life refers to how long the product performs once it is actually in use. A tubing set in a fluid path may face cyclic loading, chemical contact, or repeated stress that is very different from what it sees on the shelf. A reusable device may experience repeated cleaning and disinfection. A closure may be punctured multiple times or exposed to long-term compression and chemical contact. These are different life questions, and they do not always call for the same protocol.

Being explicit about which question is being asked helps make the study more useful. It also helps avoid placing too much weight on a single result when the product may need to perform across several different kinds of aging conditions.

Another important part of study design is deciding what to measure.

The most convenient metric is not always the most meaningful one. A property may be easy to test in the lab and still have only a loose connection to the way the product actually fails in use. That is why aging studies are strongest when the measured response is closely tied to product performance.

Depending on the application, that might mean burst pressure, elongation retention, compression set, seal integrity, clarity, permeability, dimensional stability, friction, flex life, or another application-specific measure. In many cases, one metric is not enough. A material may hold its tensile strength reasonably well while becoming less flexible. A component may remain dimensionally stable while its optical or surface properties shift. A seal may still pass a bench test while long-term reseal behavior changes in a way that matters in the field.

The more clearly those measurements connect back to end-use requirements, the more meaningful the aging data becomes.

This is especially helpful when comparing materials or constructions. It keeps the study focused on what matters most: not whether a property changed, but whether the product still performs the way it needs to.

Why real-time aging still matters

Even the best accelerated aging study is still a model. That is why real-time aging remains such an important companion.

Real-time studies take longer, but they provide the reference point that helps confirm whether the accelerated protocol is capturing the right behavior. They can validate the assumptions built into the study, help refine future protocols, and provide an early signal if the accelerated condition is not tracking real-world aging as closely as expected.
For that reason, accelerated and real-time aging are often most powerful when they are run in parallel. Accelerated aging provides earlier insight that can support development timelines and decision-making. Real-time aging provides the longer-term confirmation that builds confidence in the extrapolation.

Both have value. One helps teams move faster. The other helps ensure the faster answer still reflects reality.

Accelerated aging can be an extremely useful tool for estimating product life, but confidence comes from more than applying heat and calculating time. The strongest programs are built on an understanding of what the product needs to do, which material properties support that performance, which stressors are relevant, and which degradation mechanisms are most likely to matter over time.

That is why accelerated aging is at its best when material science, application knowledge, and test strategy are all working together. With the right upfront thinking, it is possible to design studies that provide earlier answers without losing sight of the real-world behavior those answers are meant to predict.

For medical products, that kind of confidence matters. It supports development, strengthens product claims, and helps teams make better decisions with a clearer understanding of long-term risk.

Accelerated aging may compress time, but the goal is not simply to move faster. It is to understand product life more clearly, and to do so in a way that remains meaningful when the product reaches the field.